No Result
View All Result
  • Home
  • Stock Watchlist
  • Stock Analyst News
  • Earnings News
  • Insider Trades
  • Dividend Stocks
Subscribe Now
  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports
No Result
View All Result
HOME MARKET SECTORS STOCK BUYS INSIDER TRADES DIVIDEND STOCKS
     BACK TO MENU Technology Health Finance Consumer Commercial Services Electronic Communications Transportation Utilities Minerals Other Sectors Electric Vehicles Pot Stock 5G Stock Crypto
healthtechmovers.com
No Result
View All Result

3 HealthTech Stocks up over 112% past 10 days (CRVS stock, VIRX stock, PIII stock)

by Staff Editor
May 22, 2023
in Health Health Technology Health Services Watchlist 

Today, our screeners were at work and below is a list of 3 HealthTech Stocks up over 112% past 10 days and have been added to our watchlist.  These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.

HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.

Corvus Pharmaceuticals, CRVS

Summary: Corvus Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of immuno-oncology therapies to harness the immune system to attack cancer cells. Its products include CPI-444, Adenosine production inhibitor, Adenosine A2B antagonist and Interleukin-2 (IL-2)-inducible T cell kinase (ITK) inhibitors. Corvus Pharmaceuticals, Inc. is based in Burlingame, California.
Recent CRVS Stock Price (approx 10:00am EST.): $3.31
Previous Close for CRVS Stock: $3.19
Percentage Price Change Past 10 Days for CRVS stock: +166% 

TipRanks.com reports that Corvus Pharmaceuticals stock currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for CRVS stock with an average price target is $3.75. 

What is the forecast for CRVS stock? Here are 3rd party ratings for CRVS stock: 

  • TipRanks.com rating for CRVS stock: Moderate Buy
  • TradingView.com for CRVS stock: : Buy
  • Yahoo! Finance for CRVS stock: : Bullish
  • Barchart.com for CRVS stock: : Strong buy
  • Zacks Rating for CRVS stock: : Top 45% (115 out of 251)
What’s the sentiment on the street for CRVS stock?
Current ratings compiled by TipRanks.com) 
  • News Sentiment for CRVS stock: : Very Bullish
  • Blogger Consensus for CRVS stock: : ―
  • Media Buzz for CRVS stock: : Very Low
  • Insider Signal for CRVS stock: : Positive
  • Investor Sentiment for CRVS stock: : ―
  • Hedge Fund signal for CRVS stock: : Neutral

Click for the CRVS stock Chart >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Viracta Therapeutics, VIRX

Summary: Viracta Therapeutics Inc. is a precision oncology company targeting virus-associated malignancies. The company is pursuing application of inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma and other virus-related cancers. Viracta Therapeutics Inc., formerly known as Sunesis Pharmaceuticals Inc., is based in SAN DIEGO.
Recent VIRX Stock Price (approx 10:00am EST.): $2.27
Previous Close for VIRX Stock: $2.13
Percentage Price Change Past 10 Days for VIRX stock: +113% 

TipRanks.com reports that Viracta Therapeutics stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating for VIRX stock with an average price target is $16.75. 

What is the forecast for VIRX stock? Here are 3rd party ratings for VIRX stock: 

  • TipRanks.com rating for VIRX stock: Strong Buy
  • TradingView.com for VIRX stock: : Buy
  • Yahoo! Finance for VIRX stock: : Bullish
  • Barchart.com for VIRX stock: : Weak sell
  • Zacks Rating for VIRX stock: : Top 47% (118 out of 251)
What’s the sentiment on the street for VIRX stock?
Current ratings compiled by TipRanks.com) 
  • News Sentiment for VIRX stock: : Very Bullish
  • Blogger Consensus for VIRX stock: : ―
  • Media Buzz for VIRX stock: : Very High
  • Insider Signal for VIRX stock: : ―
  • Investor Sentiment for VIRX stock: : Very Positive
  • Hedge Fund signal for VIRX stock: : Neutral

Click for the VIRX stock Chart >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

P3 Health Partners, PIII

Summary: P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Recent PIII Stock Price (approx 10:00am EST.): $4.17
Previous Close for PIII Stock: $3.85
Percentage Price Change Past 10 Days for PIII stock: +112% 

What is the forecast for PIII stock? Here are 3rd party ratings for PIII stock: 

  • TipRanks.com rating for PIII stock: n/a
  • TradingView.com for PIII stock: : Buy
  • Yahoo! Finance for PIII stock: : Bullish
  • Barchart.com for PIII stock: : buy
  • Zacks Rating for PIII stock: : Top 37% (93 out of 251)
What’s the sentiment on the street for PIII stock?
Current ratings compiled by TipRanks.com) 
  • News Sentiment for PIII stock: : Very Bullish
  • Blogger Consensus for PIII stock: : Bullish
  • Media Buzz for PIII stock: : Medium
  • Insider Signal for PIII stock: : Very Positive
  • Investor Sentiment for PIII stock: : ―
  • Hedge Fund signal for PIII stock: : Neutral

Click for the PIII stock Chart >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------


Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com. 

The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.

HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.

Tags: VIRX stock price VIRX news Viracta Therapeutics news healthtech stocks CRVS stock price 

Related Posts

From Shrinkflation to Economic Collapse: Is a Financial Storm Brewing?

Oct 13, 2024

The Week Ahead: Earnings Season Kicks Off and Retail Sales in Focus

Oct 13, 2024
Dividend 

4 Stocks Up 30%+ in 5 Days: EV, Lithium, and Tech Leaders

Oct 09, 2024
UP Fintech Holding Limited stock TIGR TIGR price target Financial Services stock watchlist Financial Services stocks 

4 Soaring Stocks Up Over 46% in 5 Days

Oct 04, 2024
Dividend 

3 Dividend Stocks Up Over 30% in the Last Week

Oct 04, 2024

Massive "Backdoor" Pre-IPO Play in Musk's $100 Billion Starlink?

Oct 03, 2024
Next Post
Canadian regulator rejects Enbridge plan to contract oil pipeline space

Canadian regulator rejects Enbridge plan to contract oil pipeline space

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

No Result
View All Result

Screener data might be 15 minutes delayed from the real time.

  • Newsletters
  • Advertise with Us
  • About Us
  • Feedback/Contact Us
  • Email Notice, Data Use and DMCA
  • Privacy Policy
  • Terms of Use and Disclaimer
  • 17B List of Disclosures
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This site contains articles and videos are offered for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation or be relied upon as personalized investment advice. We are a financial publisher. We are not financial advisors and cannot give personalized advice. There is a risk of loss in all trading, and you may lose some or all of your original investment. Results presented are not typical. Never make any investment or trade with our first consulting with your investment advisor and after doing your own due diligence. This webpage and website is protected by copyright laws of the United states and international treaties.

©2021 Sandpiper Marketing Group
PO Box 407. Mt. Mourne, NC 28123-0407

  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports

©2021 Sandpiper Marketing Group

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In